Skip to contentM
Marimed Inc.
M
MRMDMarimed Inc. Q2 2021 · 10-Q
Revenue$32.57M$32.57M+238.9% vs Q2 2020 Net Income$7.49M$7.49MN/M vs Q2 2020 EPS Diluted$0.02$0.02— vs Q2 2020 Gross Profit$19,406,000+215.1% Operating Income
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Marimed Inc. · CIK 1522767 · Engraved from SEC EDGAR
Operating Cash Flowderived$10,833,000+1,044.0% Free Cash Flowderived$5,165,000N/M Margins · derivedGross margin59.6%−4.5 pt vs Q2 2020
Operating margin36.9%+15.0 pt vs Q2 2020
Net margin23.0%+35.6 pt vs Q2 2020
ended Jun 30, 2021 · filed Aug 16, 2021 · 47 d after period end